| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
5
5
4
5
1
|
|
Zacks Investment Research
3
(Hold)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
B-
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Short | % Net | |
|---|---|---|---|
| Cash | 21.76 | 18.78 | 2.99 |
| Stocks | 0.0 | 0.0 | 0.0 |
| Bonds | 0.0 | 0.0 | 0.0 |
| Other | 1.55 | 0.0 | 1.55 |
| Foreign Bonds | 0.0 | 0.0 | 0.0 |
| Foreign Stocks | 96.56 | 1.09 | 95.46 |
| Convertible | 0.0 | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 | 0.0 |
Updated 11.30.2012
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 11.30.2012
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Roche Holding AG | RHHVF | 23.65 | 3.48 |
| Novo Nordisk A/S | NONOF | 5.13 | 2.99 |
| Diageo PLC | DGE | --- | 2.77 |
| British American Tobacco PLC | BATS | --- | 2.75 |
| Nestle SA | NSRGF | 9.65 | 2.6 |
| Future Contract On Dax Index Future Dec12 /Eur/ | --- | --- | 2.1 |
| GlaxoSmithKline PLC | GLAXF | 20.09 | 1.77 |
| Rio Tinto PLC | RTPPF | -21.57 | 1.64 |
| Anheuser-Busch Inbev SA | AHBIF | 9.81 | 1.52 |
| Sap AG | SAP | --- | 1.42 |
